Political strategy and corporate communications agency Lodestone has launched its Health Advisory Unit after a series of successful client wins that has seen it significantly strengthen its presence in the UK health sector.
Led by Chairman David Wild, Lodestone’s Health Advisory Unit recently added the University Hospitals Birmingham NHS Foundation Trust (UHB) to its portfolio of health clients, alongside the Countess of Chester Hospital NHS Foundation Trust which it began working with in 2019. As part of Lodestone’s remit working with UHB, David sits on a key Committee, alongside other NHS executives advising on their Improvement Alliance with Shrewsbury and Telford Hospital NHS Trust.
Lodestone’s expansion into the health industry has been further bolstered recently by its work with the tech firm Fimatix, who have launched an independent track and trace kit developed especially for workplaces and to help businesses better manage COVID-19 risks.
Lodestone has also successfully facilitated a number of in-person and virtual public affairs events that have focused on health issues, some of which hosted over 100 participants online. Events have engaged Health Secretary Matt Hancock, NHSX, Cheshire and Merseyside Health Care Partnership, digital inclusion charity Good Things Foundation, the All-Party Parliamentary Group for Technology (PICTFOR) and pharmacy provider McKesson.
David Wild, Co-Founder and Chairman of Lodestone said:
“We are delighted with the growth we have seen in our health practice since the beginning of 2020. Lodestone has a wealth of experience operating across regulated sectors and the launch of our Health Advisory Unit will enable us to more effectively help organisations in the health sector become more resilient in what is a challenging environment for them right now.”
Last June, Lodestone enhanced their offer to clients by appointing ex-PricewaterhouseCoopers Partner, Stuart Warriner as a Non-Executive Director bringing extensive board level experience to the agency.